BACKGROUND: This study is designed to develop and evaluate the feasibility of a telemedicine protocol for Community Reinforcement and Family Training (CRAFT) to improve treatment engagement and reduce distress among families of individuals diagnosed with early psychosis (EP) and co-occurring substance use.
METHODS: Participants are families and patients in a EP program in MA. Families complete the intervention, which consists of six to eight ~60 minute coaching sessions of CRAFT modified for psychosis and delivered via telemedicine (CRAFT-PT) by a study therapist.
Participants complete an assessment battery four times: pre-treatment, mid-treatment, post- treatment, and a three-month follow-up. Families also complete a survey following each session to rate their satisfaction with treatment (helpfulness and convenience). Intervention topics include building motivation and self-care, communication, functional analysis of substance use, positive reinforcement of healthy behaviors, allowing for negative consequences, and discussing treatment. The program aims to increase patients’ readiness to change their substance use, decrease families’ depression and anxiety, and improve the patient-family relationship. After 10 families complete the program, we will use qualitative data from a focus group of families in addition to session feedback, participation, and retention data to guide further treatment development and we will test the revised manual with 10 new families. The percentage of participants who complete the program, percentage of session attendance, and mean treatment satisfaction ratings will be used to evaluate the feasibility and acceptability of the intervention.
RESULTS: As of January 19, 2021, family members were all mothers who had 100% session attendance, and they rated treatment satisfaction across sessions as being near excellent (mean(SD) = 4.91(0.28)) despite experiencing technical difficulties in ~28% of sessions.
CONCLUSION: Preliminary data suggest that the CRAFT-PT protocol is feasible and acceptable to serve as the active treatment in a pilot randomized controlled trial comparing CRAFT-PT to treatment as usual.
Live Zoom Session – April 21st
Andrea J. Wood, BA, Roger Weiss, MD, Kim Mueser, PhD, Robert Meyers, PhD, Dost Öngür, MD, PhD, Julie M. McCarthy, PhD
Julie McCarthy, PhD